[go: up one dir, main page]

LU84315A1 - Spirothiazolidinedione,son procede de production et preparation pharmaceutique la contenant - Google Patents

Spirothiazolidinedione,son procede de production et preparation pharmaceutique la contenant Download PDF

Info

Publication number
LU84315A1
LU84315A1 LU84315A LU84315A LU84315A1 LU 84315 A1 LU84315 A1 LU 84315A1 LU 84315 A LU84315 A LU 84315A LU 84315 A LU84315 A LU 84315A LU 84315 A1 LU84315 A1 LU 84315A1
Authority
LU
Luxembourg
Prior art keywords
formula
compound
piperazine
salt
hydrogen
Prior art date
Application number
LU84315A
Other languages
English (en)
French (fr)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU84315A1 publication Critical patent/LU84315A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
LU84315A 1981-08-03 1982-08-03 Spirothiazolidinedione,son procede de production et preparation pharmaceutique la contenant LU84315A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/289,351 US4456756A (en) 1981-08-03 1981-08-03 Spirothiazolidinyl piperazine derivatives
US28935181 1981-08-03

Publications (1)

Publication Number Publication Date
LU84315A1 true LU84315A1 (fr) 1983-06-07

Family

ID=23111156

Family Applications (1)

Application Number Title Priority Date Filing Date
LU84315A LU84315A1 (fr) 1981-08-03 1982-08-03 Spirothiazolidinedione,son procede de production et preparation pharmaceutique la contenant

Country Status (28)

Country Link
US (1) US4456756A (xx)
JP (1) JPS5838277A (xx)
KR (1) KR880001737B1 (xx)
AT (1) AT380477B (xx)
AU (1) AU555870B2 (xx)
BE (1) BE894021A (xx)
CA (1) CA1208642A (xx)
CH (1) CH655503B (xx)
DE (1) DE3228992A1 (xx)
DK (1) DK156219C (xx)
ES (2) ES514263A0 (xx)
FI (1) FI76794C (xx)
FR (1) FR2510571B1 (xx)
GB (1) GB2105714B (xx)
GR (1) GR76171B (xx)
HU (1) HU191505B (xx)
IE (1) IE53613B1 (xx)
IL (1) IL66433A (xx)
IT (1) IT1149026B (xx)
LU (1) LU84315A1 (xx)
NL (1) NL8203035A (xx)
NZ (1) NZ201158A (xx)
OA (1) OA07171A (xx)
PH (1) PH18688A (xx)
PT (1) PT75365B (xx)
SE (1) SE453503B (xx)
YU (1) YU44073B (xx)
ZA (1) ZA825481B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61162278A (ja) * 1985-01-09 1986-07-22 Nippon Yakin Kogyo Co Ltd 冷却手段を具えたロ−ラ−電極を含む自走式シ−ム溶接機
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
ATE81123T1 (de) * 1987-11-20 1992-10-15 Hoechst Roussel Pharma 3-(4(1-substituierte-4-piperazinyl)butyl>-4thiazolidinone, verfahren zu deren herstellung und ihre anwendung als arzneimittel.
JPH0270878U (xx) * 1988-11-21 1990-05-30

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL265085A (xx) * 1960-05-24
US3106552A (en) * 1960-07-19 1963-10-08 Geschickter Fund Med Res Nu-substituted azaspiranes and azaspirane-diones and processes for their preparation
US3200118A (en) * 1961-10-31 1965-08-10 Geschickter Fund Med Res Spirocyclic hydrazine imides
US3432499A (en) * 1965-04-02 1969-03-11 Geschickter Fund Med Res Trifluoromethylazaspiranes and azaspirane diones
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
DE1695410A1 (de) * 1967-04-20 1971-04-08 Merck Patent Gmbh Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
DE2862059D1 (en) * 1977-12-29 1982-11-11 Synthelabo Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications
IL57569A0 (en) * 1978-06-20 1979-10-31 Synthelabo Phenylpiperazine derivative,their preparation and pharmaceutical compositions containing them
US4367335A (en) * 1981-08-03 1983-01-04 Mead Johnson & Company Thiazolidinylalkylene piperazine derivatives

Also Published As

Publication number Publication date
ES8401763A1 (es) 1984-01-01
BE894021A (fr) 1983-02-03
KR840001166A (ko) 1984-03-28
GR76171B (xx) 1984-08-03
YU158582A (en) 1985-04-30
AU8597382A (en) 1983-02-10
CH655503B (xx) 1986-04-30
PH18688A (en) 1985-09-05
ES514263A0 (es) 1984-01-01
SE8204549D0 (sv) 1982-08-02
FR2510571B1 (fr) 1987-07-10
PT75365A (en) 1982-09-01
GB2105714A (en) 1983-03-30
IT8248901A0 (it) 1982-07-28
HU191505B (en) 1987-02-27
IL66433A0 (en) 1982-12-31
CA1208642A (en) 1986-07-29
NZ201158A (en) 1985-12-13
ES526149A0 (es) 1985-04-16
FI822666L (fi) 1983-02-04
KR880001737B1 (ko) 1988-09-10
ES8504185A1 (es) 1985-04-16
FR2510571A1 (fr) 1983-02-04
IL66433A (en) 1985-10-31
IT1149026B (it) 1986-12-03
PT75365B (en) 1985-11-20
JPH039912B2 (xx) 1991-02-12
ATA299382A (de) 1985-10-15
IE53613B1 (en) 1988-12-21
DK156219B (da) 1989-07-10
AU555870B2 (en) 1986-10-16
ZA825481B (en) 1983-04-27
JPS5838277A (ja) 1983-03-05
FI76794C (fi) 1988-12-12
SE453503B (sv) 1988-02-08
YU44073B (en) 1990-02-28
DK156219C (da) 1989-12-04
GB2105714B (en) 1985-05-15
FI76794B (fi) 1988-08-31
US4456756A (en) 1984-06-26
DE3228992A1 (de) 1983-02-17
AT380477B (de) 1986-05-26
SE8204549L (sv) 1983-02-04
OA07171A (fr) 1984-04-30
NL8203035A (nl) 1983-03-01
IE821851L (en) 1983-02-03
DK343782A (da) 1983-02-04
FI822666A0 (fi) 1982-07-30

Similar Documents

Publication Publication Date Title
EP0058146B1 (fr) Nouveaux acides 2-(4-(diphénylméthyl)-1-pipérazinyl)-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
EP0955295B1 (fr) 1-((4-chlorophényl) phénylméthyl) pipérazines de forme lévogyre ou dextrogyre thérapeutiquement actives
LU84550A1 (fr) Derives de piperazine portant un radical de benzisothiazole ou de benzisoxazole
FR2555585A1 (fr) Derives de la 1-heteroaryl-4 ((2,5-pyrrolidinedion-1-yl) alkyl )piperazine, leur procede de preparation et leur application pharmacologique
EP0202164B1 (fr) Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique
LU84316A1 (fr) Nouvelles thiazolidinediones,leur procede de production et preparation pharmaceutique les contenant
JPS61267580A (ja) チアゾリジン誘導体
LU84011A1 (fr) 2-phenoxyalkyl-1,2,4-triazol-3-ones antidepressives
LU85796A1 (fr) Derives antipsychotiques de la 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine
CZ295346B6 (cs) Pyrimidinové sloučeniny, způsob jejich přípravy, farmaceutická kompozice a jejich použití pro léčbu poruch souvisejících s ligandy dopaminu D3
FR2531085A1 (fr) Nouveaux derives de la xanthine, leur procede de preparation et les compositions pharmaceutiques les renfermant
WO2007119001A2 (fr) Derives d 'aminomethyl pyridine, leur preparation et leur application en therapeutique
HUT68256A (en) Substituted (arylalkoxybenzyl)aminopropanamide derivatives, their preparation and pharmaceutical compns. with ant-epileptic, neuroprotective and antidepressant activity, contg. the said compds
LU84315A1 (fr) Spirothiazolidinedione,son procede de production et preparation pharmaceutique la contenant
EP2643307B1 (fr) Derives de nitrobenzothiazoles et leur utilisation pour le traitment de la tubercolose
EP0084993B1 (fr) Nouveaux dérivés de benzodioxine, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
EP0364350B1 (fr) Dérivés de méthyl-4[(phényl-4 pipérazinyl-1)-2 éthyl]-5 thiazole, leur procédé de préparation et les compositions pharmaceutiques en contenant
US20060135785A1 (en) Alpha-phenyl acetanilide derivatives having an acat inhibiting activity and the therapeutic application thereof
LU86421A1 (fr) Derives de piperazine 1,4-disubstitues,composition pharmaceutique les contenant;leur procede d'obtention
CA1139763A (fr) Procede d'obtention de nouveaux aryltrifluoroethanols
FR2558158A1 (fr) Derives de l'indole ethenyl phenol, leurs sels, procede de preparation, application a titre de medicaments, compositions les renfermant et intermediaires
EP2313384B1 (fr) Phenyl-alkyl piperazines ayant une activite modulatrice du tnf
CA2108064C (fr) Nouveaux composes de thiazolidine dione, leur procede de preparation et les compositions pharmaceutiques les contenant
LU86405A1 (fr) Derive antipsychotique du benzisothiazole s-oxyde
EP0005091B1 (fr) Nouvelles pipérazines monosubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant